Propranolol Hydrochloride — Drug Intelligence | 13 EU Trials

Filter these 13 trials by condition, phase, country and more.

Open in Search →

13 Registered trials

8 Recruiting

2 Completed trials

14 Sponsors

9 Countries

Phase III

Phase II

Phase IV

Phase III: 2 Phase II: 5 Phase III/IV: 1 Phase IV: 4 Phase I (Other): 1

Oversight events:

1 serious breach 1 temporary halt 1 urgent safety measure across 1 trial

View oversight register →

Indications tested

Angiosarcoma 1 Retinopathy of prematurity 1 Malignant glioma 1

Sponsors using this IMP

Amsterdam UMC 1 Andrea Di Marco 1 Centre Hospitalier Regional De Marseille 1 Centre Hospitalier Universitaire De Nantes 1 Heidelberg University Hospital AöR 1 Hopital Erasme 1 Institut Universitari D Investigacio En Atencion Primaria Jordi Gol 1 Janssen - Cilag International 1 Region Hovedstaden 1 Rigshospitalet 1 Spanish Society Of Cardiology 1 Universitaetsklinikum Tuebingen AöR 1

All trials

13 total

Women victims of violences : PTSD treatment by traumatic memory reactivation under the influence of propranolol (VIOFEM) Pending

2025-523107-30-01 Phase III 1 country Centre Hospitalier Universitaire De Toulouse
EFFICACY OF PROPRANOLOL IN TRAUMATIC BRAIN INJURY PATIENTS ADMITTED TO THE ICU: A PROSPECTIVE, RANDOMIZED, TRIPLE-BLIND STUDY (ProP TBI in I… Pending

2025-524194-17-00 Phase III 1 country University Hospital Son Espases
Withdrawal of neurohormonal therapy in patients with non-ischemic cardiomyopathy, no late gadolinium enhancement, and negative genetic testi… Recruiting

2025-521780-12-00 Phase III/IV 1 country Andrea Di Marco
Optimal drug therapy for the suppression of ventricular arrhythmias in Andersen-Tawil syndrome and multifocal ectopic Purkinje-related prema… Recruiting

2024-510682-42-01 Phase IV 1 country Amsterdam UMC
Clinical trial to compare the effectiveness of migraine’s preventive treatments in primary care Recruiting

2024-513597-22-00 Phase IV 1 country Institut Universitari D Investigacio En Atencion Primaria Jordi Gol
Oral Propranolol for prevention of threshold retinopathy of prematurity Recruiting

2024-511338-10-01 Phase II 1 country Universitaetsklinikum Tuebingen AöR; Universität Zürich - Klinik für Neonatologi…
Long-term neuropsychologic outcome of pre-emptive mTOR inhibitor treatment in children with tuberous sclerosis complex (TSC) under 4 months … Recruiting

2022-502332-39-00 Phase II 2 countries Heidelberg University Hospital AöR
Evaluation of the effectiveness of the reconsolidation therapy in a clinical population suffering from post-traumatic stress disorder Recruiting

2022-500870-32-02 Phase II 1 country Hopital Erasme
A phase 2 trial on propranolol in combination with pembrolizumab in advanced Angiosarcoma and Undifferentiated Pleomorphic Sarcoma Recruiting

2024-513727-16-00 Phase II 3 countries Region Hovedstaden
The RIME-IVF study - Investigation of RIsk factors in out-of-hospital-cardiac-arrest patients, and MEdical treatment in Idiopathic Ventricul… Recruiting

2024-518057-41-00 Phase IV 1 country Rigshospitalet
Randomized open-label Phase 2 trial evaluating the impact of enhanced versus standard dermatologic management on selected dermatologic adver… Ended

2023-505863-35-00 Phase II 3 countries Janssen - Cilag International
Randomized clinical trial assessing the value of Beta-Blockers and Antiplatelet Agents in patients with Spontaneous Coronary Artery Dissecti… Ended

2024-516039-28-00 Phase IV 1 country Spanish Society Of Cardiology
Phase 1 study of a Propranolol (HEMANGIOL®) and oral metronomic Vinorelbine (NAVELBINE®) combination on children and teenagers With Refracto… Halted

2024-517185-42-00 Phase I (Other) 1 country Centre Hospitalier Regional De Marseille

Showing 1–13 of 13 trials

← All drugs A–Z